Cite
The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound.
MLA
Serruys, P. W., et al. “The TRAPIST Study. A Multicentre Randomized Placebo Controlled Clinical Trial of Trapidil for Prevention of Restenosis after Coronary Stenting, Measured by 3-D Intravascular Ultrasound.” European Heart Journal, vol. 22, no. 20, Jan. 2001, pp. 1938–47. EBSCOhost, https://doi.org/10.1053/euhj.2001.2627.
APA
Serruys, P. W., Foley, D. P., Pieper, M., Kleijne, J. A., & de Feyter on behalf of the TRAPIST investigators, P. J. (2001). The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound. European Heart Journal, 22(20), 1938–1947. https://doi.org/10.1053/euhj.2001.2627
Chicago
Serruys, P.W., D.P. Foley, M. Pieper, J.A. Kleijne, and P.J. de Feyter on behalf of the TRAPIST investigators. 2001. “The TRAPIST Study. A Multicentre Randomized Placebo Controlled Clinical Trial of Trapidil for Prevention of Restenosis after Coronary Stenting, Measured by 3-D Intravascular Ultrasound.” European Heart Journal 22 (20): 1938–47. doi:10.1053/euhj.2001.2627.